| AASLD | American Association for the Study of Liver Diseases |
| AFP | Alpha-fetoprotein |
| ALP | Alkaline Phosphatase |
| ALT | Alanine Aminotransferase |
| AST | Aspartate Aminotransferase |
| AUC | Area Under the Curve |
| BCLC | Barcelona Clinic Liver Cancer |
| cDNA | Complementary DNA |
| CI | Confidence Interval |
| CRP | C-reactive Protein |
| Ct | Cycle Threshold |
| DCR | Disease Control Rate |
| ECOG | Eastern Cooperative Oncology Group |
| ECL | Electrochemiluminescence |
| GGT | Gamma-Glutamyl Transferase |
| HCC | Hepatocellular Carcinoma |
| HCV | Hepatitis C Virus |
| HR | Hazard Ratio |
| INR | International Normalized Ratio |
| IQR | Interquartile Range |
| LnRNA = lncRNA | Long Noncoding RNA |
| MALAT1 | Metastasis-Associated Lung Adenocarcinoma Transcript 1 |
| OS | Overall Survival |
| qPCR | Quantitative Polymerase Chain Reaction |
| RECIST | Response Evaluation Criteria in Solid Tumors |
| ROC | Receiver Operating Characteristic |
| RT | Reverse Transcription |
| SD | Standard Deviation |
| TTP | Time-To-Progression |
| TLR4/NF-κB | Toll-like Receptor 4/Nuclear Factor Kappa B |
| UCA1 | Urothelial Carcinoma-Associated 1 |